Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform

KELOWNA, BC, March 30, 2026 /PRNewswire/ — Doseology Sciences Inc. (CSE: MOOD |OTCQB: DOSEF | FSE: VU70) („Doseology“ or the „Company„) a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it has arranged a non-brokered private placement of up to 3,225,806 units (each, a „Unit„) at a price of $0.62 per Unit to raise aggregate gross proceeds of up to $2,000,000 (the „Offering„).

Each Unit will consist of one common share in the capital of the Company (each, a „Share„) and one Share purchase warrant (each, a „Warrant„). Each Warrant will entitle the holder to acquire one additional Share at a price of $1.00 per Share for a period of two (2) years from the date of issuance, subject to acceleration. If the daily volume weighted  average  trading  price  of  the  Shares  on  the  Canadian Securities Exchange (the „CSE„) (or such other exchange on which the Shares may become traded) for  any  period  of  20  consecutive  trading  days  equals  or  exceeds $2.00, at any time following the date that is four (4) months and one (1) day after the closing of the Offering, the Company may, upon providing written notice to the holders of the Warrants (the „Acceleration Notice„), accelerate the expiry date of the Warrants to the date that is 30 days following the date of the Acceleration Notice. If the Warrants are not exercised by the accelerated expiry date, the Warrants will expire and be of no further force or effect.